|
InTheNews
MIP-DILI Using 3D Liver Spheroids
Remarking that 3D Liver Spheroids provide "superior biological relevance...scalability and compatibility," leaders of the MIP-DILI consortium are moving forward with further testing of liver spheroids as a means to predict clinical safety of new drugs. Read the press release.
InSphero IP Portfolio Continues Growth
Users of the GravityPLUS™ Cell Culture and Assay Platform know first-hand the benefits our technology brings to their 3D workflow. International IP protection for our technology grew in 2014, and our scientists continue their mission to bring novel 3D technology to your bench top. Read more.
|
InFocus
3D InSight™ Liver Microtissues
InSphero's assay-ready 3D InSight™ Human, Rat and HepG2 Liver Microtissues are setting the standard for long-lived, organotypic in vitro models for safety testing, DMPK studies, mechanistic toxicity, and disease modeling. Learn more in our on-demand webinars.
|
|
InPress
Lab Automation: Spheroid-based Body on Chip
The December 18 issue of Laboratory Automation featured a glimpse into the future of Body-on-a-Chip technology. Co-authored by InSphero's Dr. Jens Kelm and Dr. David Fluri, the system allows connection of up to 66 microtissues of different cell types. View the PubMed abstract.
We Published, You Shared!
Did you miss our nanotox article in last October's Particle and Fibre Toxicology? Those who read it tended to pass it along, as it ranked as one of the "Top 4 Social" articles the journal published last year. Learn more.
|
InPerson
Meet InSphero at SLAS 2015
Heading to SLAS in Washington, DC? Visit our SLAS conference page to learn more about our meeting activities. Highlights include a podium presentation by CSO and co-founder Dr. Jens M. Kelm featuring recent body on a chip work, as well as our 3D cell culture short course, 3D cell-based assay tutorial, and more. Join us!
|
|
|
|
Meet Us Here - Fairs & Events
SLAS, Washington, DC, Feb 7-11
ENDO, San Diego, CA, Mar 5-8
Bayern Innovativ Life Sciences Forum, Munich, DE, March 11-12
SOT, San Diego, CA, Mar 21-25
|
|
|
|